Jane Street’s NextCure NXTC Stock Holding History

Jane Street’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.4K	Buy	+32,725	New	+$242K	﹤0.01%	10915
2024 Q3	–	Sell	-1,612	Closed	-$30.8K	–	10154
2024 Q2	$30.8K	Buy	+1,612	New	+$31.4K	﹤0.01%	9003
2023 Q1	–	Sell	-1,979	Closed	-$33.5K	–	9658
2022 Q4	$33.5K	Buy	+1,979	New	+$45.5K	﹤0.01%	8475
2022 Q2	–	Sell	-1,255	Closed	-$73K	–	10493
2022 Q1	$73K	Buy	+1,255	New	+$78.5K	﹤0.01%	9565
2021 Q3	–	Sell	-1,260	Closed	-$121K	–	10491
2021 Q2	$121K	Buy	+1,260	New	+$129K	﹤0.01%	9172
2020 Q3	–	Sell	-939	Closed	-$242K	–	7679
2020 Q2	$242K	Buy	+939	New	+$358K	﹤0.01%	6138

Other funds holding NXTC

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Verdad Advisers Boston, Massachusetts $104M AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Jane Street's NXTC Position: Q2 2026 in Review

Jane Street opened a new position in NextCure (NXTC) in Q2 2026: 32,725 shares worth $52.4K. The stake represents ﹤0.01% of the portfolio and ranks #10915 among its holdings. This is a return to the name: Jane Street previously reported a position in NXTC as recently as Q2 2024.

Jane Street first reported a position in NXTC in Q2 2020 and has held it in 6 quarters since. The position peaked at $242K in Q2 2020. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

Jane Street held 32,725 shares of NextCure worth $52.4K as of Q2 2026.
NextCure was a new Jane Street position in Q2 2026.
NextCure made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10915 holding.
Jane Street first reported a position in NextCure in Q2 2020 and has held it in 6 quarters since.
Jane Street's NextCure position peaked at $242K in Q2 2020.
30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.